This study therefore investigates serum myostatin and irisin levels in RA patients, analyzing their clinical correlations with sarcopenia and OP, particularly OPF, to identify potential biomarkers and therapeutic targets for future research. Here, FNDC5 is linked to rheumatoid arthritis.